论文信息 - NICE guidance on ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer. - 字舞流文

NICE guidance on ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer.

H. Knight | N. Umeweni | C. Hall | Lindsay Smith

[1] Andreas Sashegyi,et al. Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial , 2014, The Lancet.